Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3946811 | 0.78 | GPR84 (0.62) | GPR84 | |
| Ethyne SCHEMBL28448752 | 0.74 | GPR84 (0.58) | GPR84 | |
| SCHEMBL5675901 | 0.71 | MEN1 (0.32) | — | |
| Ammonia Solution, Strong SCHEMBL3949938 | 0.69 | GPR84 (0.53) | GPR84 | |
| SCHEMBL5677598 | 0.68 | PTPN1 (0.40) | — | |
| SCHEMBL102781 | 0.67 | MEN1 (0.37) | — | |
| SCHEMBL2781483 | 0.67 | GPR84 (0.50) | GPR84 | |
| SCHEMBL29624824 | 0.67 | GPR84 (0.50) | GPR84 | |
| SCHEMBL11486708 | 0.67 | GPR84 (0.50) | GPR84 | |
| SCHEMBL6371108 | 0.67 | GPR84 (0.50) | GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060036109-A1 | Tropylideneamines and use thereof | LANXESS DEUTSCHLAND GMBH (DE) | 2006-02-16 | — | — | US | disclosed |
| EP-1614674-A2 | Tropylideneamines and their use | Lanxess Deutschland GmbH (DE) | 2006-01-11 | — | — | EP | disclosed |
| US-20050283014-A1 | Bistropylidenediamines and use thereof | LANXESS DEUTSCHLAND GMBH (DE) | 2005-12-22 | — | — | US | disclosed |
| EP-1604973-A1 | Bistropylidenediamines and their use | Lanxess Deutschland GmbH (DE) | 2005-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060036109-A1 | Tropylideneamines and use thereof | PNMT, INMT, HNMT | GPR84 2068/4885 |
| US-20050283014-A1 | Bistropylidenediamines and use thereof | FHIT, BTD, HNMT | GPR84 2275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.